March 1st, 2014 - Volume 65 - Issue 3 - Contributor Index

A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF ...

Wohl, David A.; Cohen, Calvin; Gallant, Joel E.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(3):e118-e120, March 1st, 2014.

A Randomized, Double-blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir DF...

Clumeck, Nathan; Molina, Jean-Michel; Henry, Keith; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(3):e121-e124, March 1st, 2014.

Morbidity and Health care Resource Utilization in HIV-Infected Children After Antiretroviral Therapy Initiation in Côte d'Ivoire, 2004–2009

Desmonde, Sophie; Essanin, Jean-Bosco; Aka, Addi E.; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(3):e95-e103, March 1st, 2014.

  • IOR articles

Antiviral Activity, Pharmacokinetics, and Safety of the HIV-1 Protease Inhibitor TMC310911, Coadministered With Ritonavir, in Treatment-Naive HIV-1–Infected Patients

Stellbrink, Hans-Jürgen; Arastéh, Keikawus; Schürmann, Dirk; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(3):283-289, March 1st, 2014.

Safety and Pharmacokinetics of the HIV-1 Protease Inhibitor TMC310911 Coadministered With Ritonavir in Healthy Participants: Results From 2 Phase 1 Studies

Hoetelmans, Richard M.W.; Dierynck, Inge; Smyej, Ilham; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(3):299-305, March 1st, 2014.

Impact of CMV Therapy With Valganciclovir on Immune Activation and the HIV Viral Load in Semen and Blood: An Observational Clinical Study

Shin, Lucy Y.; Sheth, Prameet M.; Persad, Desmond; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(3):251-258, March 1st, 2014.

Author:
Dow, Anna PhD
Author:
Dube, Queen MD